SKI Market

Indian Indices

Sensex

85,041.45 -367.25
( -0.43%)

Global Indices

Nasdaq

48,728.27 -23.90
(-0.05%)

Dow Jones

6,949.98 -3.07
(-0.04%)

Hang Seng

50,641.54 233.75
(0.46%)

Nikkei 225

9,870.68 -18.54
(-0.19%)

Forex

USD-INR

89.83 0.26
(0.29%)

EUR-INR

105.77 0.25
(0.24%)

GBP-INR

121.29 0.43
(0.36%)

JPY-INR

0.58 0.00
(0.43%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5600262

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

23.39

121573.61

EPS(TTM)

Face Value()

Div & Yield %

64.35

1.06

Back

Ksolves India consolidated net profit declines 8.49% in the September 2025 quarter

Oct 15,2025

Net profit of Ksolves India declined 8.49% to Rs 8.41 crore in the quarter ended September 2025 as against Rs 9.19 crore during the previous quarter ended September 2024. Sales rose 13.93% to Rs 39.67 crore in the quarter ended September 2025 as against Rs 34.82 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	39.67	34.82	14
OPM %	30.43	37.97	-
PBDT	12.05	13.23	-9
PBT	11.26	12.59	-11
NP	8.41	9.19	-8

85,041.45 -367.25 ( -0.43%)

48,728.27 -23.90 (-0.05%)

6,949.98 -3.07 (-0.04%)

50,641.54 233.75 (0.46%)

9,870.68 -18.54 (-0.19%)

89.83 0.26 (0.29%)

105.77 0.25 (0.24%)

121.29 0.43 (0.36%)

0.58 0.00 (0.43%)